Actively Recruiting
Is Intraligamentary Injection the Anesthesia of Choice for Symptomatic Irreversible Pulpitis in Mandibular Molars? A Multicenter Randomized Comparative Trial.
Led by Aula Dental Avanzada · Updated on 2025-08-19
52
Participants Needed
2
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The trial investigates two methods of anesthesia for patients with symptomatic irreversible pulpitis in mandibular molars, a condition that makes pain control during dental treatment challenging. This randomized study aims to compare the effectiveness of intraligamentary injection and inferior alveolar nerve block in controlling pain during endodontic access. The research is conducted across multiple dental centers using standardized criteria and validated pain scales. Participants will be randomly assigned to receive either intraligamentary anesthesia with 2% lidocaine and epinephrine using a dental syringe or the conventional inferior alveolar nerve block with the same anesthetic solution. These procedures are administered before the dental access to evaluate which technique better eliminates pain. The study is single-blinded and includes follow-up measures at the end of treatment and seven days later. During the trial, pain will be assessed immediately after access cavity preparation. Additional measurements include the need for supplementary anesthesia during the procedure, patient satisfaction both immediately and at seven days post-treatment, and postoperative pain at seven days. Participants will be monitored through follow-up visits and data collection to evaluate the outcomes and safety of each anesthesia method. The total participation time includes the initial treatment and a one-week follow-up.
CONDITIONS
Brief Title
Intraligamentary vs Inferior Alveolar Nerve Block for Pulpitis: A Randomized Clinical Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Presenting with symptomatic irreversible pulpitis in a mandibular molar
- Vital response to cold testing
- Ability to understand and provide informed consent
- Available for follow-up and data collection
You will not qualify if you...
- Known allergy to lidocaine or epinephrine
- Pregnancy or breastfeeding
- Use of analgesics or anti-inflammatory drugs in the previous 6 hours
- Non-vital or previously treated teeth
- Significant systemic disease (ASA III or above)
- History of psychiatric or neurological disorders affecting pain perception
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single treatment visit
Participants receive either intraligamentary injection or inferior alveolar nerve block anesthesia prior to endodontic access to treat symptomatic irreversible pulpitis in mandibular molars.
1 visit (in-person)
Duration - 7 days after treatment
Participants are monitored for postoperative pain and satisfaction after treatment.
1 follow-up visit
Trial Site Locations
Total: 2 locations
1
Clínica Dental 4
Ferrol, A coruña, Spain, 15402
Actively Recruiting
2
Clínica Dental Esteve
Alicante, Alicante, Spain, 03001
Actively Recruiting
Research Team
G
Guillem Esteve-Pardo, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here